chr22-31870720-C-T

Variant summary

Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PM2PP2BP4_Strong

The NM_001242896.3(DEPDC5):​c.3461C>T​(p.Ser1154Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000878 in 1,583,666 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000094 ( 0 hom. )

Consequence

DEPDC5
NM_001242896.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:7O:1

Conservation

PhyloP100: 0.982
Variant links:
Genes affected
DEPDC5 (HGNC:18423): (DEP domain containing 5, GATOR1 subcomplex subunit) This gene encodes a member of the IML1 family of proteins involved in G-protein signaling pathways. The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates cell growth by sensing the availability of nutrients. The protein encoded by this gene is a component of the GATOR1 (GAP activity toward Rags) complex which inhibits the amino acid-sensing branch of the mTORC1 pathway. Mutations in this gene are associated with autosomal dominant familial focal epilepsy with variable foci. A single nucleotide polymorphism in an intron of this gene has been associated with an increased risk of hepatocellular carcinoma in individuals with chronic hepatitis C virus infection. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), DEPDC5. . Gene score misZ 2.6501 (greater than the threshold 3.09). Trascript score misZ 3.7275 (greater than threshold 3.09). GenCC has associacion of gene with focal epilepsy, Brugada syndrome, epilepsy, familial focal, with variable foci 1, familial focal epilepsy with variable foci, autosomal dominant epilepsy with auditory features, autosomal dominant nocturnal frontal lobe epilepsy.
BP4
Computational evidence support a benign effect (MetaRNN=0.06171015).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DEPDC5NM_001242896.3 linkuse as main transcriptc.3461C>T p.Ser1154Phe missense_variant 34/43 ENST00000651528.2 NP_001229825.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DEPDC5ENST00000651528.2 linkuse as main transcriptc.3461C>T p.Ser1154Phe missense_variant 34/43 NM_001242896.3 ENSP00000498382 P4O75140-10

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152162
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000816
AC:
18
AN:
220714
Hom.:
0
AF XY:
0.0000416
AC XY:
5
AN XY:
120152
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000363
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000164
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000943
AC:
135
AN:
1431504
Hom.:
0
Cov.:
31
AF XY:
0.0000984
AC XY:
70
AN XY:
711586
show subpopulations
Gnomad4 AFR exome
AF:
0.0000313
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000118
Gnomad4 OTH exome
AF:
0.0000677
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152162
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74330
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000154
Hom.:
0
Bravo
AF:
0.0000491
ExAC
AF:
0.0000414
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:4
Uncertain significance, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Uncertain significance, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Uncertain significance, criteria provided, single submitterclinical testingAthena DiagnosticsFeb 01, 2019- -
Uncertain significance, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMar 01, 2024Variant summary: DEPDC5 c.3461C>T (p.Ser1154Phe) results in a non-conservative amino acid change in the encoded protein sequence. Three of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 8.2e-05 in 220714 control chromosomes. c.3461C>T has been reported in the literature in three individuals from one family, among whom, one individual was affected with Temporal Lobe Epilepsy, the second individual was noted with unclassified phenotype, and the third individual was reported to be unaffected (Ricos_2016). These report(s) do not provide unequivocal conclusions about association of the variant with Epilepsy, Familial Focal, With Variable Foci 1. At least one publication reports experimental evidence evaluating an impact on protein function. These results showed no damaging effect of this variant by measuring the DEPDC5 expression and the affect on mTORC1 activity (Dawson_2019). The following publications have been ascertained in the context of this evaluation (PMID: 27208208, 31639411, 26505888). ClinVar contains an entry for this variant (Variation ID: 264763). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Familial focal epilepsy with variable foci Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpAug 04, 2023This missense change has been observed in individual(s) with clinical features of DEPDC5-related conditions (PMID: 26505888). This variant is present in population databases (rs578244490, gnomAD 0.01%). This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 1154 of the DEPDC5 protein (p.Ser1154Phe). ClinVar contains an entry for this variant (Variation ID: 264763). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change does not substantially affect DEPDC5 function (PMID: 31639411). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. -
DEPDC5-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesJan 31, 2023The DEPDC5 c.3461C>T variant is predicted to result in the amino acid substitution p.Ser1154Phe. This variant was reported in an family with epilepsy, however the variant did not segregate with the disease completely (Ricos et al. 2016. PubMed ID: 26505888 Figure 2). Functional studies show that this variant does not significantly affect the protein function (Dawson et al. 2019. PubMed ID: 31639411). This variant is reported in 0.015% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/22-32266706-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Epilepsy, familial focal, with variable foci 1 Other:1
not provided, no classification providedliterature onlyGeneReviews-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
21
DANN
Uncertain
0.98
DEOGEN2
Benign
0.015
.;.;.;.;.;T;.;.;.;.;T;.;.;.;.
Eigen
Benign
-0.32
Eigen_PC
Benign
-0.21
FATHMM_MKL
Benign
0.34
N
LIST_S2
Uncertain
0.90
D;D;D;D;D;D;.;.;D;D;.;D;.;D;D
M_CAP
Benign
0.023
T
MetaRNN
Benign
0.062
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.34
.;.;.;.;.;N;.;.;.;.;N;.;.;N;.
MutationTaster
Benign
1.0
D;N;N;N;N;N;N;N;N
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.51
N;.;.;.;.;N;N;.;.;.;N;.;N;N;.
REVEL
Benign
0.025
Sift
Benign
0.32
T;.;.;.;.;D;T;.;.;.;T;.;T;T;.
Sift4G
Benign
0.53
T;.;.;.;.;.;T;.;.;.;T;.;.;T;.
Polyphen
0.37
.;.;B;.;.;.;.;.;.;.;.;.;B;.;.
Vest4
0.17
MVP
0.11
MPC
0.50
ClinPred
0.048
T
GERP RS
3.8
Varity_R
0.048

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs578244490; hg19: chr22-32266706; COSMIC: COSV56697540; COSMIC: COSV56697540; API